TY - JOUR
T1 - False-positive intercellular cement substance antibodies due to group A/B red cell antibodies
T2 - Frequency and approach
AU - Lee, Frederick J.
AU - Silvestrini, Roger
AU - Fulcher, David A.
PY - 2010/10
Y1 - 2010/10
N2 - Aim: Antibodies to the intercellular cement substance of skin (ICSA) are characteristic of pemphigus vulgaris, and are commonly detected by indirect immunofluorescence (IIF). However, false-positive staining may arise when blood group antibodies, directed against A and B red cell antigens, bind to epitopes of similar distribution in the substrate. We sought to determine the frequency of such false-positive ICSA staining and to establish optimal conditions for its elimination. Methods: IIF was performed on 100 de-identified routine serum samples of known blood group (A, B or O), along with serum from four pemphigus patients. Blocking was performed on samples which displayed typical ICSA staining using either a mixture of soluble A and B antigens in solution ('soluble A/B antigens'), or red blood cells from a group AB donor ('AB-RBCs'). Results: ICSA staining was detected in 12 of 100 (12) routine samples at a titre of between 1:10 and 1:160, and was most frequent in (but not restricted to) samples of blood group O (10/54, 19). Blocking with soluble A/B antigens eliminated staining in 10 of 12 (83) samples, whilst blocking with AB-RBCs eliminated staining in 11 of 12 (92); one sample failed to block using either method, suggesting true ICSA reactivity. Blocking had no effect on the positive pemphigus samples, the titres of which were significantly higher (1:160 to 1:640). Conclusions: Staining of the intercellular cement substance arising from group A/B red cell antibodies is common, particularly but not exclusively in patients of blood group O, making blocking mandatory in the routine evaluation of samples with such staining, particularly in a hospital-based population. Blocking using either soluble A/B antigens or AB-RBCs appears to be of comparable efficacy, although the former method is more convenient for a diagnostic laboratory.
AB - Aim: Antibodies to the intercellular cement substance of skin (ICSA) are characteristic of pemphigus vulgaris, and are commonly detected by indirect immunofluorescence (IIF). However, false-positive staining may arise when blood group antibodies, directed against A and B red cell antigens, bind to epitopes of similar distribution in the substrate. We sought to determine the frequency of such false-positive ICSA staining and to establish optimal conditions for its elimination. Methods: IIF was performed on 100 de-identified routine serum samples of known blood group (A, B or O), along with serum from four pemphigus patients. Blocking was performed on samples which displayed typical ICSA staining using either a mixture of soluble A and B antigens in solution ('soluble A/B antigens'), or red blood cells from a group AB donor ('AB-RBCs'). Results: ICSA staining was detected in 12 of 100 (12) routine samples at a titre of between 1:10 and 1:160, and was most frequent in (but not restricted to) samples of blood group O (10/54, 19). Blocking with soluble A/B antigens eliminated staining in 10 of 12 (83) samples, whilst blocking with AB-RBCs eliminated staining in 11 of 12 (92); one sample failed to block using either method, suggesting true ICSA reactivity. Blocking had no effect on the positive pemphigus samples, the titres of which were significantly higher (1:160 to 1:640). Conclusions: Staining of the intercellular cement substance arising from group A/B red cell antibodies is common, particularly but not exclusively in patients of blood group O, making blocking mandatory in the routine evaluation of samples with such staining, particularly in a hospital-based population. Blocking using either soluble A/B antigens or AB-RBCs appears to be of comparable efficacy, although the former method is more convenient for a diagnostic laboratory.
KW - Antibodies
KW - Immunofluorescence
KW - Intercellular cement substance antibodies
KW - Pemphigus
KW - Skin disorders
UR - http://www.scopus.com/inward/record.url?scp=77956925726&partnerID=8YFLogxK
U2 - 10.3109/00313025.2010.508792
DO - 10.3109/00313025.2010.508792
M3 - Article
SN - 0031-3025
VL - 42
SP - 574
EP - 577
JO - Pathology
JF - Pathology
IS - 6
ER -